Dormakaba Q1 organic sales up 4% on price increases; outlook confirmed
Dormakaba reported Q1 2026/27 organic sales growth of 4%, driven by price increases and volume growth. Total net sales rose 5.2% to CHF 702.9 million. The company confirmed its full-year outlook, citing resilience amid geopolitical challenges. Three acquisitions were completed in the quarter. CEO Till Reuter highlighted a strong order book in access solutions.
How this was made
The 30-second read
Why it matters
The Q1 results and reaffirmed FY outlook provide fresh data for valuation models and may trigger short‑term buying pressure.
Market read
First‑time disclosure of Q1 organic sales growth and FY guidance, offering a concrete trading catalyst.
What to watch
Currency headwinds and geopolitical tensions could dampen future growth.
Background
Dormakaba is a Swiss-based provider of access solutions that recently completed three bolt‑on acquisitions in the UK and US.
Market effects
Positive signal for the access control and security solutions sector, may boost peers.
European security hardware market may see slight uplift.
Limited to investors tracking Swiss industrial stocks.
Counterpoint
Guidance may already be priced in; execution risk could limit upside.
Key entities
- companyDormakaba Holding AG
Swiss security solutions provider.



